BiliCheck vs JM-103 in identifying neonates not at risk of hyperbilirubinaemia

详细信息    查看全文

• 作者：Costantino Romagnoli (1) (2)
  Piero Catenazzi (1)
  Giovanni Barone (1)
  Lucia Giordano (1)
  Riccardo Riccardi (1)
  Antonio Alberto Zuppa (1)
  Enrico Zecca (1)
  
• 关键词：Newborn ; Neonatal jaundice ; Transcutaneous bilirubin measurements
• 刊名：Italian Journal of Pediatrics
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：39
• 期：1
• 全文大小：288KB
• 参考文献：1. Maisels MJ, Kring E: Length of stay, jaundice, and hospital readmission. / Pediatrics 1998, 101:995-98. CrossRef
  2. Ip S, Lau J, Chung M, Kulig J, Sege R, Glicken S, O’Brien R: Hyperbilirubinemia and kernicterus: 50 years later. / Pediatrics 2004, 114:263-64. CrossRef
  3. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK: A comparison of alternative risk assessment strategies for predicting significant neonatal hyperbilirubinaemia in term and near-term infants. / Pediatrics 2008, 121:e170-e179. CrossRef
  4. Riskin A, Tamir A, Kugelman A, Hemo M, Bader D: Is Visual Assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? / J Pediatr 2008, 152:782-87. CrossRef
  5. Bhutani VK, Johnson L, Sivieri EM: Predictive ability of a predischarge hour specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. / Pediatrics 1999, 103:6-4. CrossRef
  6. Burke BL, Robbins JM, Bird M, Hobbs CA, Nesmith C, Tilford JM: Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-005. / Pediatrics 2009, 123:524-32. CrossRef
  7. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD: The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. / Pediatrics 2006, 117:e855-e862. CrossRef
  8. Mah MP, Clark SL, Akhigbe E, Englebright J, Frye DK, Meyers JA, Perlin JB, Rodriguez M, Shepard A: Reduction of significant hyperbilirubinemia after institution of predischarge bilirubinscreening. / Pediatrics 2010, 125:e1143-e1148. CrossRef
  9. Maisels MJ, Kring E: Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. / Pediatrics 1997, 99:599-01. CrossRef
  10. Mishra S, Chawla D, Agarwal R, Deorari AK, Paul VK, Bhutani VK: Transcutaneous bilirubinometry reduces the need for blood sampling in neonates with visible jaundice. / Acta Paediatr 2009, 98:1916-919. CrossRef
  11. Carceller-Blanchard A, Cousineau J, Delvin EE: Point of care testing: Transcutaneous bilirubinometry in neonates. / Clin Biochem 2009, 42:143-49. CrossRef
  12. Karon BS, Teske A, Santrach PJ, Cook WJ: Evaluation of the BiliChek noninvasive bilirubin analyzer for prediction of serum bilirubin and risk of hyperbilirubinemia. / Am J Clin Pathol 2008, 130:976-82. CrossRef
  13. Ahmed M, Mostafa S, Fisher G, Reynolds TM: Comparison between transcutaneous bilirubinometry and total serum bilirubin measurements in preterm infants <35 weeks gestation. / Ann Clin Biochem 2010, 47:72-7. CrossRef
  14. Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley WH: Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. / Pediatrics 2002, 110:61-7. CrossRef
  15. De Luca D, Zuppa AA, Cota F, Zecca E, Romagnoli C: Multiwavelenght transcutaneous bilirubinometry: suitability and cost analysis. / Ital J Pediatr 2006, 32:328-29.
  16. Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R: Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. / J Med Assoc Thai 2005, 88:1187-193.
  17. Maisels MJ, Kring E: Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of ?5 weeks-gestation. / Pediatrics 2006, 117:1169-173. CrossRef
  18. De Luca D, Romagnoli C, Tiberi E, Zuppa AA, Zecca E: Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. / Acta Paediatr 2008, 97:146-50. CrossRef
  19. Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A: Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. / Pediatrics 2010, 125:e52-e57. CrossRef
  20. Yu Z-B, Dong X-Y, Han S-P, Chen Y-L, Qiu Y-F, Sha L, Sun Q, Guo XR: Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late preterm Chinese infants. / Eur J Pediatr 2011, 170:185-91. CrossRef
  21. Maisels MJ, DeRidder JM, Kring EA, Balasubramaniam M: Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinaemia. / J Perinatol 2009, 29:612-17. CrossRef
  22. Romagnoli C, Tiberi E, Barone G, De Curtis M, Regoli D, Paolillo P, Picone S, Anania S, Finocchi M, Cardiello V, Zecca E: Validation of transcutaneous bilirubin nomogram in identifying neonates not at risk of hyperbilirubinaemia: A prospective, observational, multicenter study. / Early Hum Dev 2012, 88:51-5. CrossRef
  23. Romagnoli C, Zecca E, Catenazzi P, Barone G, Zuppa AA: Transcutaneous bilirubin measurement: comparison of Respironics BiliCheck and JM-103 in a normal newborn population. / Clin Biochem 2012,45(9):659-62. CrossRef
  24. Raimondi F, Lama S, Landolfo F, Sellitto M, Borrelli AC, Maffucci R, Milite P, Capasso L: Measuring transcutaneous bilirubin: a comparative analysis of three devices on a multiracial population. / BMC Pediatr 2012, 12:70. CrossRef
  25. AAP Subcommittee on Hyperbilirubinaemia: Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. / Pediatrics 2004, 114:297-16. CrossRef
  26. Catz C, Hanson JW, Simpson L, Yaffe SJ: Summary of workshop: early discharge and neonatal hyperbilirubinemia. / Pediatrics 1995, 96:743-45.
  27. Bhutani VK, Maisels MJ, Stark AR, Buonocore G: Expert Committee for Severe Neonatal Hyperbilirubinemia; European Society for Pediatric Research; American Academy of Pediatrics Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants-gt;?or--5 weeks gestation. / Neonatology 2008,94(1):63-7. CrossRef
  28. Fay DL, Schellhase KG, Suresh GK: Bilirubin screening for normal newborns: a critique of the hour-specific bilirubin nomogram. / Pediatrics 2009, 124:1203-205. CrossRef
  29. Slaughter J, Annibale D, Suresh G: False-negative results of pre-discharge neonatal bilirubin screening to predict significant hyperbilirubinemia: a need for caution. / Eur J Pediatr 2009, 168:1461-466. CrossRef
  30. Rodriguez-Capote K, Kim K, Paes B, Turner D, Grey V: Clinical implication of the difference between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinaemia. / Clin Biochem 2009, 42:176-79. CrossRef
  
• 作者单位：Costantino Romagnoli (1) (2)
  Piero Catenazzi (1)
  Giovanni Barone (1)
  Lucia Giordano (1)
  Riccardo Riccardi (1)
  Antonio Alberto Zuppa (1)
  Enrico Zecca (1)
  
  1. Division of Neonatology, Department of Pediatrics, Catholic University Sacred Heart, Rome, Italy
  2. Division of Neonatology, Policlinico A. Gemelli, Catholic University Sacred Heart, Largo A. Gemelli, 8, 00168, Rome, Italy
  

文摘

Background Transcutaneous bilirubinometry is widely used to predict hyperbilirubinemia by using several devices. The aim of this study was to compare the predictive ability of BiliCheck vs JM-103 in identifying neonates not at risk of significant hyperbilirubinemia, putting the data obtained with the two instruments on our transcutaneous bilirubin nomogram built with the BiliCheck. Methods Transcutaneous bilirubin (TcB) measurement was performed when jaundice appeared in newborn babies and/or just before discharge from the hospital. It was performed at the forehead with the two instruments within 5?minutes by two experienced neonatologists, each one blind to the value obtained by the other. Blood samples were drawn to obtain total serum bilirubin (TSB) levels soon after TcB measurements. Results A total of 627 paired-sample measurements were obtained from 298 newborn babies. Out of the total population studied, 16 newborn babies (5.4%) showed significant hyperbilirubinemia defined as TSB value >17?mg/dL, or as need for phototherapy treatment according to the AAP guidelines. TcB measurements showed false negative results in the first 60?hours of life using both devices. After the 60th hour of life, TcB measurements using both devices successfully predicted newborn babies not at risk of significant hyperbilirubinemia, being the JM-103 more reliable than BC because of fewer false positive results. Conclusions Our study shows that both BC and JM-103 can exclude subsequent significant hyperbilirubinemia when the measurements are performed after the 60th hour of life. Nevertheless, the transcutaneous pre-discharge screening should be considered only as the first step, and it has to be followed by a follow-up through the first days after discharge.